Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
Petrovic
M
M
Derom
E
E
Baele
G
G
D001323:Autoantibodies / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000209:etiology* / Q000276:immunology; D006469:Hemoptysis / Q000209:etiology; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide; D005169:Factor VIII; D011241:Prednisone